Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: Development of recommendations for clinical practice based on data from the literature and experts opinion;Les traitements médicamenteux (hors biothérapie) dans la prise en charge de patients atteints de rhumatisme psoriasique périphérique :élaboration de recommandations pour la pratique clinique, à partir d'une analyse systématique de la littérature et de l'opinion d'experts

Revue du Rhumatisme (Edition Francaise)

Volumn 74, Issue SUPPL.2, 2007, Pages 31-38

  Dernis, Emmanuelle ^a   Lavie, Fréderic ^b   Salliot, Carine ^c   Flipo, René Marc ^d   Saraux, Alain ^e   Maillefert, Jean Francis ^f   Paul, Carle ^g   Goupille, Philippe ^h   Cantagrel, Alain ⁱ   Claudepierre, Pascal ^j   Gaudin, Philippe ^k   Tebib, Jacques ^l   Wendling, Daniel ^m   Schaeverbeke, Thierry ⁿ   Le Loët, Xavier ^o   Combe, Bernard ^p  

^a CENTRE HOSPITALIER   (France)

^b université Paris Cité   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f DIJON UNIVERSITY HOSPITAL   (France)

^g CHU PURPAN   (France)

^h UNIVERSITY HOSPITAL OF TOURS   (France)

ⁱ CHU RANGUEIL   (France)

^j HENRI MONDOR HOSPITAL   (France)

^k Hopital Sud   (France)

^l CENTRE HOSPITALIER LYON SUD   (France)

^m UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁿ HÔPITAL PELLEGRIN   (France)

^o ROUEN UNIVERSITY HOSPITAL   (France)

^p LAPEYRONIE HOSPITAL   (France)

more..

Author keywords

Everyday clinical practice; Leflunomide; Methotrexate; Psoriatic arthritis; Recommendations; Spondylarthropathy; Sulfasalazine; Treatment

Indexed keywords

EID: 39049137518     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(07)78645-3     Document Type: Article

References (28)

1. Saraux A., Guillemin F., Guggenbuhl P., Roux C.H., Fardellone P., Le Bihan E., et al. Prevalence of spondyloarthropathies in France:2001. Ann Rheum Dis 64 (2005) 1431-1435
2. Pham T., Guillemin F., Claudepierre P., Luc M., Miceli-Richard C., Fautrel B., et al. TNF alpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis:recommendations of the French Society for Rheumatology. Joint Bone Spine 73 (2006) 547-553
3. Pham T., Gossec L., Fautrel B., Combe B., Flipo R.M., Goupille P., et al. Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 72 (2005) 222-228
4. Salliot C., Dernis E., Lavie F., Cantagrel A., Gaudin P., Wendling D., et al. Diagnostic du rhumatisme psoriasique de forme périphérique: élaboration de recommandations pour la pratique clinique, à partir d'une analyse systématique de la littérature et de l' opinion d'experts. Rev Rhum 74 HS4 (2007) 3-11
5. Shekelle P.G., Woolf S.H., Eccles M., and Grimshaw J. Clinical guidelines: developing guidelines. BMJ 318 (1999) 593-596
6. Peeters A.J., Dijkmans B.A., and van der Schroeff J.G. Fumaric acid therapy for psoriatic arthritis. A randomized, double-blind, placebo-controlled study. Br J Rheumatol 31 (1992) 502-504
7. Sarzi-Puttini P., Santandrea S., Boccassini L., Panni B., and Caruso I. The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulide. Clin Exp Rheumatol 19 (2001) S17-S20
8. Hilliquin P., Gregoir C., and Menkes C.J. Value of pulse methylpred-nisolone in polyarticular forms of psoriatic rheumatism. Rev Rhum Mal Osteoartic 59 (1992) 160-161
9. Jones G., Brooks P., and Crotty M. Interventions for treating psoriatic arthritis. The Cochrane Database of Systematic Reviews Issue 3 (2000)
10. Clegg D.O., Reda D.J., Mejias E., Cannon G.W., Weisman M.H., Taylor T., et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39 (1996) 2013-2020
11. Combe B., Goupille P., Kuntz J.L., Tebib J., Liote F., and Bregeon C. Sulphasalazine in psoriatic arthritis:a randomized, multicentre, placebo-controlled study. Br J Rheumatol 35 (1996) 664-668
12. Dougados M., van der Linden S., Leirisalo-Repo M., Huitfeldt B., Juhlin R., Veys E., et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38 (1995) 618-627
13. Farr M., Kitas G.D., Waterhouse L., Jubb R., Felix-Davies D., and Bacon P.A. Sulphasalazine in psoriatic arthritis:a double-blind placebo-controlled study. Br J Rheumatol 29 (1990) 46-49
14. Fraser S.M., Hopkins R., Hunter J.A., Neumann V., Capell H.A., and Bird H.A. Sulphasalazine in the management of psoriatic arthritis. Br J Rheumatol 32 (1993) 923-925
15. Gupta A.K., Grober J.S., Hamilton T.A., Ellis C.N., Siegel M.T., Voorhees J.J., et al. Sulfasalazine therapy for psoriatic arthritis:a double blind, placebo controlled trial. J Rheumatol 22 (1995) 894-898
16. Rahman P., Gladman D.D., Cook R.J., Zhou Y., and Young G. The use of sulfasalazine in psoriatic arthritis:a clinic experience. J Rheumatol 25 (1998) 1957-1961
17. Black R.L., O'Brien W.M., Vanscott E.J., Auerbach R., Eisen A.Z., and Bunim J.J. Methotrexate therapy in psoriatic arthritis;double-blind study on 21 patients. JAMA 189 (1964) 743-747
18. Willkens R.F., Williams H.J., Ward J.R., Egger M.J., Reading J.C., Clements P.J., et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 27 (1984) 376-381
19. Salvarani C., Macchioni P., Olivieri I., Marchesoni A., Cutolo M., Fer-raccioli G., et al. A comparison of ciclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol 28 (2001) 2274-2282
20. Spadaro A., Riccieri V., Sili-Scavalli A., Sensi F., Taccari E., and Zoppini A. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis:a one-year prospective study. Clin Exp Rheumatol 13 (1995) 589-593
21. Fraser A.D., van Kuijk A.W.R., Westhovens R., Karim Z., Wakefield R., Gerards A.H., et al. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 64 (2005) 859-864
22. Kaltwasser J.P., Nash P., Gladman D., Rosen C.F., Behrens F., Jones P., et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis. A multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 50 (2004) 1939-1950
23. Levy J., Paulus H.E., Barnett E.V., Sokoloff M., and Bangert R. Pearson cm. A double-blind controlled evaluation of azathioprine treatment in rheumatoid arthritis and psoriatic arthritis. Arthritis Rheum 15 (1972) 116-117
24. Kavanaugh A.F., and Ritchlin C.T. Systematic review of treatments for psoriatic arthritis:an evidence based approach and basis for treatment guidelines. J Rheumatol 33 (2006) 1417-1421
25. Strober B.E., Siu K., and Menon K. Conventional systemic agents for psoriasis. A systematic review. J Rheumatol 33 (2006) 1442-1446
26. Paul C, Guibal F. Evaluation de la sévérité du psoriasis:importance du dialogue médecin-patient. (Soumis pour publication à Annales de dermatologie Mai 2007).
27. Pariser D.M., Bagel J., Gelfand J.M., Korman N.J., Ritchlin C.T., Strober B.E., et al. National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143 (2007) 239-242
28. Kumar N., Kay L.J., and Walker D.J. The treatment of enthesitis in psoriatic arthritis. J Rheumatol 31 (2004) 2311-2312